Lophius Biosciences GmbH

• Kurzinfo

• • Forschung & Entwicklung
• Gründungsjahr 2002
• 20 Beschäftigte (Standort)
• Umsatz: keine Angabe

Produkte/Leistungen: Lophius Biosciences has developed and is currently marketing: A CE marked in-vitro diagnostic (IVD) system T-Track® CMV, which is intended to improve prognosis of clinical complications in immunocompromized patients i.e. CMV virus reactivation and transplant rejection. T Cell Tools for the support of your research projects. Further diagnostic systems in the area of EBV infections in immunocompromized patients, tuberculosis, and multiple sclerosis are currently under development.